Prelude Therapeutics Incorporated (PRLD) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Prelude Therapeutics Incorporated (PRLD) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $259.7M, listed on NASDAQ, employing roughly 131 people, carrying a beta of 1.10 to the broader market. Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. Led by Krishna Vaddi, public since 2020-09-25.
Snapshot as of May 14, 2026.
- Spot Price
- $4.48
- Total OI
- 3.7K